Routine hepatitis B virus DNA testing in human immunodeficiency virus-infected patients with positive hepatitis b core antibody but negative hepatitis b surface antigen is not justified by current evidence

Hepatology

Volumn 51, Issue 3, 2010, Pages 1087-1088

  Núñez, Marina ^a  

^a WAKE FOREST UNIVERSITY HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ANTIRETROVIRUS AGENT; HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; VIRUS DNA;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; CLINICAL ASSESSMENT; COST BENEFIT ANALYSIS; DIAGNOSTIC PROCEDURE; HEPATITIS B VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HYPOTHESIS; IMMUNOASSAY; INCIDENCE; LETTER; NONHUMAN; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS;

DIAGNOSTIC TESTS, ROUTINE; DNA, VIRAL; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B CORE ANTIGENS; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HIV INFECTIONS; HUMANS;

EID: 77950597000     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.23395     Document Type: Letter

References (10)

1. Lok ASF, McMahon B. Chronic hepatitis B: Update 2009. HEPATO-LOGY 2009;50:661-662.
2. Núñez M, Ŕos P, Pérez-Olmeda M, Soriano V. Lack of 'occult' hepatitis B virus infection in HIV-infected patients. AIDS 2002;16:2099-2101.
3. Neau D, Winnock M, Jouvencel AC, Faure M, Castéra L, Legrand E, et al. Occult hepatitis B virus infection in HIV-infected patients with isolated antibodies to hepatitis B core antigen: Aquitaine cohort 2002-2003. Clin Infect Dis 2005;40:750-753.
4. Rodŕguez-Torres M, Gonzales-Garcia J, Bräu N, Solá R, Moreno S, Rockstroh J, et al. APRICOT Investigators Occult Hepatitis B virus infection in the setting of hepatitis C virus (HCV) and human immunodeficiency virus (HIV) co-infection: clinically relevant or a diagnostic problem? J Med Virol 2007;79:694-700.
5. Shire NJ, Rouster SD, Rajicic N, Sherman KE. Occult hepatitis B in HIV-infected patients. J Acquir Immune Defic Syndr 2004;36:869-875.
6. Lo Re VL 3rd, Frank I, Gross R, Reddy KR, Mounzer K, Zemel BS, et al. Prevalence, risk factors, and outcomes of occult hepatitis B virus infection among HIV-infected patients. J Acquir Immune Defic Syndr 2007;44:315-320.
7. Pogany K, Zaajier HL, Prins JM, Wit FW, Lange JM, Beld MG. Occult hepatitis B virus infection before and 1 year after start of HAART in HIV type-1 positive patients. AIDS Res Hum Retroviruses 2005;21:922-926.
8. Hofer M, Joller-Jemelka HI, Grob PJ, Luthy R, Opravil M. Frequent chronic hepatitis B virus infection in HIV infected patients positive for antibody to hepatitis B core antigen only. Swiss HIV cohort study. Eur J Clin Microbiol Infect Dis 1998;17:6-13.
9. Piroth L, Binquet C, Vergne M, Minello A, Livry C, Bour JB, et al. The evolution of hepatitis B virus serological patterns and the clinical relevance of isolated antibodies to hepatitis B core antigen in HIV infected patients. J Hepatol 2002;36:681-686.
10. Morsica G, Ancarani F, Bagaglio S, Maracci M, Cicconi P, Cozzi AL, et al. Occult hepatitis B virus infection in a cohort of HIV-positive patients: correlation with hepatitis C virus coinfection, virological and immunological features. Infection 2009;37:445-449.